MedPath

Effect of a traditional medicine Qurs-e Tabasheer on diabetes and diabetic nephropathy

Phase 3
Recruiting
Conditions
Diabetes, Diabetic nephropathy.
Type 2 diabetes mellitus with kidney complications
E11.2
Registration Number
IRCT20220224054116N1
Lead Sponsor
Alborz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with diabetes and diabetic nephropathy
Patients receiving a stable dose of ACEI or ARB
eGFR between 15 and 30 (stage 4 CKD)
Albuminuria more than 30 mg/day
Patients over 18 years old

Exclusion Criteria

Patients with liver disease, active infection, malignancy
Patients with kidney disease from nondiabetic cause
Problems with nutrient absorption in gastrointestinal tract
Sensitivity to drug components
Pregnant or lactating women

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath